HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T V Lasukova Selected Research

D-Penicillamine (2,5)- Enkephalin

12/2009Role of Intracellular Calcium and Cyclic Nucleotides in Realization of Cardioprotective Effects of δ(1)- and κ(1)-Opioid Receptor Agonists.
4/2009[Intracellular mechanisms of opioidergic regulation of the myocardial function during normoxia and postischemic reperfusion].
10/2006[Delta-opioid receptor activation prevents appearance of irreversible damages of cardiomyocytes and exacerbates myocardial contractility dysfunction during ischemia and reperfusion].
10/2004Delta-opioid receptor antagonists exhibit properties of partial delta-receptor agonists in isolated perfused heart.
7/2004[Antiarrhythmic and cardioprotective effect of stimulation of delta1-opiate receptors in myocardial ischemia and reperfusion].
5/2002[Contribution of delta1-opioid receptors in regulation of cardiac resistance to ischemia-reperfusion].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T V Lasukova Research Topics

Disease

21Ischemia
03/2019 - 08/2000
3Coronary Occlusion
07/2017 - 10/2002
3Reperfusion Injury
12/2002 - 04/2001
1Body Weight (Weight, Body)
10/2020
1Hypoxia (Hypoxemia)
07/2017
1Contracture
01/2008
1Cardiac Arrhythmias (Arrythmia)
07/2004
1Myocardial Infarction
12/2002

Drug/Important Bio-Agent (IBA)

7Opioid Receptors (Opioid Receptor)IBA
10/2015 - 08/2000
6D-Penicillamine (2,5)- EnkephalinIBA
12/2009 - 05/2002
5Creatine Kinase (Creatine Phosphokinase)IBA
01/2008 - 09/2001
4Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA
10/2015 - 08/2000
4SolutionsIBA
12/2014 - 05/2002
3delta Opioid Receptors (delta Opioid Receptor)IBA
10/2006 - 10/2004
2kappa(1) opioid receptorIBA
09/2008 - 03/2008
2Pharmaceutical PreparationsIBA
01/2008 - 12/2002
2kappa Opioid Receptors (kappa Opioid Receptor)IBA
02/2007 - 12/2006
2destyrosyl- dalarginIBA
07/2004 - 01/2004
2Ala(2)-Arg(6)- enkephalin-LeuIBA
07/2004 - 01/2004
2mu Opioid Receptors (mu Opioid Receptor)IBA
09/2001 - 04/2001
1Humic SubstancesIBA
10/2020
1Nitric Oxide Synthase (NO Synthase)IBA
03/2019
1Hexamethonium (Hexamethonium Bromide)IBA
07/2017
1Adenosine Triphosphatases (ATPase)IBA
12/2009
1Cyclic NucleotidesIBA
12/2009
1(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamideIBA
12/2009
1ORALIT (ORS)IBA
03/2008
1TAN 67IBA
10/2006
1naltrindoleIBA
10/2004
1tyrosyl- tetrahydroisoquinolinecarbonyl- psi(methylamino)phenylalanyl- phenylalanineIBA
10/2004
1Opioid Analgesics (Opioids)IBA
07/2004
1Opiate AlkaloidsIBA
01/2004
1Peptides (Polypeptides)IBA
01/2004
1Trimetazidine (Vastarel)IBA
12/2002
1Thr(6)- Leu(5) Ser(2) enkephalinIBA
10/2002
1tyrosyl-arginyl-phenylalanyl-lysinamide (DALDA)IBA
09/2001
1Adenosine Triphosphate (ATP)IBA
09/2001
1KATP ChannelsIBA
09/2001
1A-factor (Streptomyces)IBA
08/2000

Therapy/Procedure

3Intravenous Injections
07/2017 - 08/2000
1Ischemic Postconditioning
12/2014
1Thrombolytic Therapy
12/2002
1Intravenous Administration
04/2001